BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cell & Gene

IASO Bio Gains NMPA Approval for Multiple Myeloma Treatment IND

IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, anno...

April 01, 2024 | News

EditCo Bio Launches with Acquisition of Synthego's Cell Engineering Divisions to Boost CRISPR Market Innovations

EditCo Bio, Inc. announced that it has launched its business with the acquisition of Synthego's engineered cell solutions and enhanced guide RNA business. ...

March 28, 2024 | News

Integrated DNA Technologies Launches Innovative Custom Vector Onboarding Tool to Streamline Gene Synthesis

Integrated DNA Technologies (IDT), a global leader in genomics solutions, announced the expansion of its gene synthesis services with the launch of a...

March 28, 2024 | News

Nanoscope Therapeutics Achieves Breakthrough in Retinitis Pigmentosa Treatment with MCO-010 Gene Therapy

Nanoscope Therapeutics, a pioneering biotechnology firm, unveiled groundbreaking results from the Phase 2b RESTORE trial of MCO-010...

March 27, 2024 | News

Andelyn Biosciences and Grace Science Partner on Gene Therapy for Rare Disease

Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has par...

March 26, 2024 | News

NeuExcell Therapeutics Launches Pioneering Gene Therapy Trial for Glioblastoma Patients

NeuExcell Therapeutics, a leading biotechnology company focused on in vivo neural regenerative therapies, announces the successful dosing of the ...

March 22, 2024 | News

European Commission Approves Bristol Myers Squibb’s Abecma as First Earlier-Line CAR T Therapy for Multiple Myeloma"

Bristol Myers Squibb announced a significant advancement in the treatment of multiple myeloma with the European Commission's approval of Abecma® (ideca...

March 21, 2024 | News

FDA Greenlights Lenmeldy, First Gene Therapy for Devastating Genetic Disorder Metachromatic Leukodystrophy

Metachromatic leukodystrophy is a debilitating, rare genetic disease affecting the brain and nervous system. It is caused by a deficiency of an enzyme call...

March 19, 2024 | News

Bristol Myers Squibb’s Breyanzi Approved as First CAR T Cell Therapy for CLL/SLL

Breyanzi offers a personalized treatment option delivered as a one-time infusion that provides deep and durable responses for patients wit...

March 15, 2024 | News

CAIR Launches Revolutionary CARES Copilot 1.0, Elevating AI in Healthcare

The Centre for Artificial Intelligence and Robotics (CAIR), under the Hong Kong Institute of Science & Innovation, Chinese Acad...

March 12, 2024 | News

ACROBiosystems Launches Initiative to Boost Ex Vivo Cell Manufacturing Support

ACROBiosystems, one of the leading providers of innovative tools and solutions used from discovery to the clinic, has announced a new corporate initiative ...

March 05, 2024 | News

CARsgen Therapeutics Receives NMPA Approval for Breakthrough Multiple Myeloma CAR T-Cell Therapy

CARsgen Therapeutics, a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that t...

March 04, 2024 | News

Andelyn Biosciences Selected for FNIH Gene Therapy Programs

Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been sele...

February 29, 2024 | News

Immunofoco Achieves Historic Dual IND Approval for Groundbreaking EpCAM CAR-T Therapy

EpCAM, known for its presence in circulating tumor cells (CTCs) and high expression in primary and metastatic lesions of gastrointestinal tumors, r...

February 26, 2024 | News

Stay Connected